Windlas Biotech Limited
NSE:WINDLAS.NS
859.85 (INR) • At close September 19, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Windlas Biotech Limited |
Symbool | WINDLAS.NS |
Munteenheid | INR |
Prijs | 859.85 |
Beurswaarde | 17,971,122,955 |
Dividendpercentage | 0.74% |
52-weken bereik | 311.6 - 952.1 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Komal Gupta |
Website | https://windlasbiotech.com |
An error occurred while fetching data.
Over Windlas Biotech Limited
Windlas Biotech Limited operates as a contract development and manufacturing organization (CDMO). Its CDMO services include product discovery, product development, licensing, and commercial manufacturing generic products, including generic products. The company provides its CMDO products and services across a range of pharmaceutical and nutraceutical conventional, and novel products for customers
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)